MYT1 and glioblastoma: When combined with the WEE1 inhibitor, it also diminished myelin transcription factor 1 (MYT1) expression, thereby promoting mitotic catastrophe.457 Moreover, PARP inhibitor rucaparib and PI3K inhibitor BKM120 had shown synergetic antitumor effects on GBM cell lines.